Tuberculosis in Wales Annual Report 2017 Data to the end of 2016

Slides:



Advertisements
Similar presentations
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Advertisements

Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
1 Identifying Cases of MDR-TB Session 3. USAID TB CARE II PROJECT Old WHO recommendations RegimenIndications 4HREZ/2HR (Category I) New cases 2SHREZ/1HREZ/5HRE.
NHS Wakefield District - Information Team Health Inequalities Gap Analysis NHS Wakefield District Information Team.
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Tuberculosis in the UK 2013 report
Tuberculosis in the UK 2014 report
The Global Plan to Stop TB, (1)
Figure 1. Number of Tuberculosis Cases: California, California Department of Public Health, Tuberculosis Control Branch Number of Tuberculosis.
1. Tuberculosis case reports, UK, Tuberculosis in the UK: 2013 report.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.
Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Tuberculosis Treatment Completion Among Persons Incarcerated at Diagnosis, U.S. TB Surveillance System, 1999–2008 Kiren Mitruka, MD, MPH (presented on.
Tuberculosis in England 2015 report (presenting data to end of 2014) Tables and figures slide set.
Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.
Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.
2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,
Number of Tuberculosis Cases: California, Number of Tuberculosis Cases.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Predictors of Failure in Timely TB Treatment Completion, United States Carla Winston,PhD TB PEN Focal Point Open Forum June 5,
Figure 1. Number of Tuberculosis Cases: California, Number of Tuberculosis Cases
Child Measurement Programme for Wales 2013/14 Annual report launch WELCOME Dr. Judith Greenacre Child Measurement Programme for Wales 2013/14.
The Strategic Health Authority for London London and TB 4 October 2007 Lynn Altass NHSL Public Health – TB North Central London TB Network Manager.
TB Control Program County of San Diego County of San Diego Health and Human Services Agency Tuberculosis Control Branch Trends in Tuberculosis Highlights.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Tuberculosis in the United States
Fracture Liaison Service Database
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
TB- HIV Collaborative activities in Romania- may 2006 status
Tuberculosis in the United States
Tuberculosis in the United States
World Tuberculosis Day 2014
Philippe Glaziou Geneva, 12 October 2009
This is an archived document.
World Tuberculosis Day 2013
World Tuberculosis Day 2014
MDR-TB Update Dr Kelvin Charambira
Tuberculosis in the United States
Influenza Vaccine Effectiveness Against Pediatric Deaths:
TUBERCULOSIS IN VIRGINIA
World Tuberculosis Day 2015
Treatment breakdown for NSCLC cancers
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Tuberculosis situation in the EU/EEA, 2016
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
World Tuberculosis Day 2014
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Further explorations of surveillance data: case detection (all cases vs. bacteriologically confirmed, All strategies) Good afternoon. I will give a brief.
HIV and STI trends in Wales: 2017
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Success and failure in TB surveillance in Hungary
Goal Objectives Expected Outcomes
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Tuberculosis in Japan Annual Report Tuberculosis Surveillance
Surveillance of Tuberculosis
EXERCISE 11: Computing and Analyzing Program Indicators
Communicable Disease Surveillance Centre, London
Surveillance, Monitoring and Evaluation Working Group
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
Health of Children and Young People: Cardiff
Tuberculosis situation in the EU/EEA, 2017
Presentation transcript:

Tuberculosis in Wales Annual Report 2017 Data to the end of 2016 Communicable Disease Surveillance Centre, Health Protection, Public Health Wales, Cardiff, UK

Number of cases and rate of TB per 100,000 population, Wales, 2007-2016

Rate of TB per 100,000 population in the UK, 2016

Rate of TB per 100,000 population by Local Authority, Wales a) 2016 b)2012-2016 © Crown Copyright and database right 2014. Ordnance Survey 100044810

Rate of TB per 100,000 population by age group and year, Wales, 2007-2016

Average annual number of TB cases and rate per 100,000 population by ethnic group, Wales, 2012-2016 Rates for ethnic groups were calculated using ONS 2011 population estimates for ethnic groups resident in Wales

Number of non-UK born TB cases, Wales, 2007-2016 During 2007-2016 between 1-13% of cases were reported with an unknown origin for place of birth.

History of or current social risk factors among TB patients, Wales, 2012-2016

Rate of TB per 100,000 population by deprivation quintile, Wales, 2016 The 2014 Welsh Index of Multiple Deprivation (WIMD) was used to assign cases to deprivation fifth using postcode of residence and Lower Super Output Area (LSOA). Rates by deprivation fifth were calculated using ONS 2014 population estimates for LSOAs. Deprivation scores from the 2014 index are not comparable to previous indices. The WIMD is an ecological measure and not all deprived people live in deprived areas and not all people in deprived areas are deprived.

Number and percentage of TB cases by site of disease, Wales, 2012-2016 Patients may have disease at more than one site Pulmonary TB includes miliary TB in accordance with the WHO’s recommendation and international reporting definitions. Revised trends in site of disease are presented for previous years using the revised WHO definitions.

Number and percentage of TB cases with bacteriological confirmation, Wales, 2012-2016 Denominator for percentage culture confirmed is total number of TB cases. Denominator for percentage of pulmonary cases culture confirmed is total number of pulmonary TB cases. Denominator for percentage of positive sputum smear pulmonary cases is the number of pulmonary cases with sputum smear taken. 1Denominator for percentage culture confirmed is total number of TB cases. 2Denominator for percentage of pulmonary cases culture confirmed is total number of pulmonary TB cases. 3Denominator for percentage of positive sputum smear pulmonary cases is the number of pulmonary cases with sputum smear taken.

Species identification in culture confirmed TB cases, Wales, 2012-2016

Number and proportion of TB cases with first line drug resistance, Wales, 2007-20161 1 Includes culture confirmed cases with drug susceptibility results for at least isoniazid and rifampicin 2 Excludes M. bovis cases

TB treatment outcome at 12 months for drug sensitive cases with expected treatment duration <12 months, Wales, 2015 Excludes initial and amplified to rifampicin resistant TB and MDR-TB cases and MDR-TB treated cases and those with CNS, spinal, miliary or cryptic disseminated TB. Not evaluated includes missing, unknown and transferred out. As treatment outcomes are reported at 12 months, treatment outcomes are only available to be reported on for cases notified in the previous year, at the time data are extracted for the report.

Last recorded TB treatment outcome for the entire drug sensitive cohort, Wales, 2015 Excludes initial and amplified to rifampicin resistant TB and MDR-TB cases and MDR-TB treated cases. Not evaluated includes missing, unknown and transferred out. As treatment outcomes are reported at 12 months, treatment outcomes are only available to be reported on for cases notified in the previous year, at the time data are extracted for the report.

All drug sensitive TB cases reported to have died at last recorded treatment outcome, Wales, 2006–2015 Excludes initial and amplified to rifampicin resistant TB and MDR-TB treated cases